Clinical Trial Update: Linperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of linperlisib with cyclophosphamide, prednisone, and thalidomide (CPT) for relapsed/refractory non-Hodgkin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Linperlisib (linperlisib)
• PREDNISONE (Prednisone)
• Thalidomide (thalidomide)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Non-Hodgkin Lymphoma | Phase 2 | Status: RECRUITING